Balance Sheet
Cash Flow Statement
Cash from Financing ActivitiesCash from Financing ActivitiesCash from OperationsCash from OperationsChange in Accured ExpensesChange in Accured ExpensesChange in CashDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesShare-based CompensationShare-based CompensationShares IssuedShort-Term Debt repayments
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Palisade Bio (PALI) Cash from Operations (2016 - 2025)

Palisade Bio has reported Cash from Operations over the past 16 years, most recently at 3144000.0 for Q4 2025.

  • Quarterly Cash from Operations fell 32.05% to 3144000.0 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was 10847000.0 through Dec 2025, up 11.04% year-over-year, with the annual reading at 10847000.0 for FY2025, 11.04% up from the prior year.
  • Cash from Operations was 3144000.0 for Q4 2025 at Palisade Bio, up from 3553000.0 in the prior quarter.
  • Over five years, Cash from Operations peaked at 1250000.0 in Q1 2021 and troughed at 3764000.0 in Q1 2022.
  • The 5-year median for Cash from Operations is 3133000.0 (2024), against an average of 2869588.24.
  • Year-over-year, Cash from Operations plummeted 201.12% in 2022 and then skyrocketed 48.07% in 2025.
  • A 5-year view of Cash from Operations shows it stood at 1250000.0 in 2021, then crashed by 164.48% to 3306000.0 in 2022, then rose by 16.94% to 2746000.0 in 2023, then grew by 13.29% to 2381000.0 in 2024, then tumbled by 32.05% to 3144000.0 in 2025.
  • Per Business Quant, the three most recent readings for PALI's Cash from Operations are 3144000.0 (Q4 2025), 3553000.0 (Q3 2025), and 1817000.0 (Q2 2025).